BG102692A - Фармацевтични форми със забавено освобождаване съдържащи мизоластин - Google Patents

Фармацевтични форми със забавено освобождаване съдържащи мизоластин

Info

Publication number
BG102692A
BG102692A BG102692A BG10269298A BG102692A BG 102692 A BG102692 A BG 102692A BG 102692 A BG102692 A BG 102692A BG 10269298 A BG10269298 A BG 10269298A BG 102692 A BG102692 A BG 102692A
Authority
BG
Bulgaria
Prior art keywords
misolastin
delayed release
pharmaceutical forms
withdelayed
oilmatrix
Prior art date
Application number
BG102692A
Other languages
English (en)
Other versions
BG63451B1 (bg
Inventor
Maryvonne Chariot
Gareth Lewis
Jean Montel
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of BG102692A publication Critical patent/BG102692A/bg
Publication of BG63451B1 publication Critical patent/BG63451B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Формата се състои от ядро, образувано от таблета със забавено освобождаване, която съдържа мизоластин, комбинирана е с маслена матрица и органична киселина е обвита.
BG102692A 1996-03-04 1998-08-12 Фармацевтични форми със забавено освобождаване съдържащи мизоластин BG63451B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602662A FR2745500B1 (fr) 1996-03-04 1996-03-04 Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine
PCT/FR1997/000355 WO1997032584A1 (fr) 1996-03-04 1997-02-28 Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine

Publications (2)

Publication Number Publication Date
BG102692A true BG102692A (bg) 1999-04-30
BG63451B1 BG63451B1 (bg) 2002-02-28

Family

ID=9489799

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102692A BG63451B1 (bg) 1996-03-04 1998-08-12 Фармацевтични форми със забавено освобождаване съдържащи мизоластин

Country Status (35)

Country Link
US (2) US6165507A (bg)
EP (1) EP0906101B1 (bg)
JP (2) JP2000512617A (bg)
KR (1) KR100369888B1 (bg)
CN (1) CN1112929C (bg)
AR (1) AR006082A1 (bg)
AT (1) ATE219365T1 (bg)
AU (1) AU725494B2 (bg)
BG (1) BG63451B1 (bg)
BR (1) BR9707827A (bg)
CA (1) CA2247405C (bg)
CO (1) CO4780020A1 (bg)
CY (1) CY2293B1 (bg)
CZ (1) CZ291418B6 (bg)
DE (1) DE69713505T2 (bg)
DK (1) DK0906101T3 (bg)
EE (1) EE03511B1 (bg)
ES (1) ES2177942T3 (bg)
FR (1) FR2745500B1 (bg)
HK (1) HK1017999A1 (bg)
HU (1) HU227472B1 (bg)
IL (1) IL126050A (bg)
IN (1) IN187739B (bg)
NO (1) NO315841B1 (bg)
NZ (1) NZ331947A (bg)
OA (1) OA10854A (bg)
PL (1) PL189813B1 (bg)
PT (1) PT906101E (bg)
RU (1) RU2173997C2 (bg)
SK (1) SK282112B6 (bg)
TR (1) TR199801574T2 (bg)
TW (1) TW491711B (bg)
UA (1) UA49004C2 (bg)
WO (1) WO1997032584A1 (bg)
ZA (1) ZA971830B (bg)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002087960A (ja) * 2000-07-14 2002-03-27 Toyama Chem Co Ltd 徐放性錠剤
DK1322158T3 (da) * 2000-10-02 2012-11-19 Usv Ltd Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
US7052706B2 (en) 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
NZ542176A (en) * 2003-03-04 2007-12-21 Nostrum Pharmaceuticals Inc Control release formulation containing a hydrophobic material as the sustained release agent
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
EP2564833B1 (en) 2008-07-28 2017-12-20 Takeda Pharmaceutical Company Limited Photostabilized pharmaceutical composition
JP5744412B2 (ja) * 2010-03-26 2015-07-08 テバ製薬株式会社 フロセミド製剤
US20140179712A1 (en) 2012-12-21 2014-06-26 Astrazeneca Ab Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364945A (en) * 1979-12-13 1982-12-21 Whittle Barry J Nasal composition for relieving nasal distress
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
FR2587029B1 (fr) * 1985-09-11 1987-10-30 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JPS62283926A (ja) * 1986-06-02 1987-12-09 Nippon Chemiphar Co Ltd 塩酸ニカルジピン持続性組成物
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
JP3195391B2 (ja) * 1991-11-14 2001-08-06 エスエス製薬株式会社 徐放性トラピジル錠
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
JPH07112932A (ja) * 1993-08-27 1995-05-02 Mitsui Toatsu Chem Inc 徐放性医薬製剤

Also Published As

Publication number Publication date
HUP9902458A2 (hu) 2000-05-28
ZA971830B (en) 1997-09-04
NO315841B1 (no) 2003-11-03
SK121098A3 (en) 1999-01-11
JP2007182451A (ja) 2007-07-19
NO984035D0 (no) 1998-09-02
TR199801574T2 (xx) 1998-11-23
IL126050A0 (en) 1999-05-09
PL328763A1 (en) 1999-02-15
ATE219365T1 (de) 2002-07-15
FR2745500A1 (fr) 1997-09-05
CA2247405A1 (en) 1997-09-12
NO984035L (no) 1998-10-22
KR100369888B1 (ko) 2003-05-17
EP0906101A1 (fr) 1999-04-07
EP0906101B1 (fr) 2002-06-19
DE69713505D1 (de) 2002-07-25
HUP9902458A3 (en) 2002-11-28
CO4780020A1 (es) 1999-05-26
WO1997032584A1 (fr) 1997-09-12
CN1112929C (zh) 2003-07-02
BG63451B1 (bg) 2002-02-28
RU2173997C2 (ru) 2001-09-27
CY2293B1 (en) 2003-07-04
HK1017999A1 (en) 1999-12-10
PT906101E (pt) 2002-09-30
HU227472B1 (en) 2011-07-28
DE69713505T2 (de) 2003-02-13
EE9800275A (et) 1999-02-15
PL189813B1 (pl) 2005-09-30
CZ279198A3 (cs) 1999-01-13
BR9707827A (pt) 1999-07-27
CA2247405C (en) 2004-04-20
US20050202089A1 (en) 2005-09-15
NZ331947A (en) 2000-03-27
OA10854A (fr) 2003-02-05
TW491711B (en) 2002-06-21
FR2745500B1 (fr) 1998-04-03
IN187739B (bg) 2002-06-15
IL126050A (en) 2004-05-12
ES2177942T3 (es) 2002-12-16
UA49004C2 (uk) 2002-09-16
US6165507A (en) 2000-12-26
AU1930097A (en) 1997-09-22
JP2000512617A (ja) 2000-09-26
CN1212624A (zh) 1999-03-31
SK282112B6 (sk) 2001-11-06
EE03511B1 (et) 2001-10-15
AR006082A1 (es) 1999-08-11
DK0906101T3 (da) 2002-10-14
AU725494B2 (en) 2000-10-12
KR19990087387A (ko) 1999-12-27
CZ291418B6 (cs) 2003-03-12

Similar Documents

Publication Publication Date Title
HUP9600924A2 (en) Aromatic hydroxamic acid derivatives, their production, use and pharmaceutical compn. contg. the said compds.
AU5112993A (en) Process for the preparation of drug pellets
PH31658A (en) Pharmaceutically active cns compounds.
AU7645894A (en) Condom restrainer ring structure with retention notch
AU1174388A (en) Sustained release dosage forms
GR3014958T3 (en) 2,4- and 2,5-Pyridine-dicarboxylic-acid derivatives, process for their preparation, their use and medicines based on these compounds.
BG102692A (bg) Фармацевтични форми със забавено освобождаване съдържащи мизоластин
GR940300095T1 (en) Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient.
CA2350659A1 (en) Pharmaceutical composition for modified release insulin sensitiser
AU2124588A (en) Pellets with enzymatically controlled drug release
NZ224622A (en) Benzoxepine, benzazepine and benzocycloheptene derivatives and pharmaceutical compositions
AU3970793A (en) Methods of manufacturing high dosage glutathione, the tablets and capsules produced thereby
EP0601909A3 (en) Dibekacin derivatives and arbekacin derivatives active against resistant bacteria, and the production thereof.
UA40616C2 (uk) Мікротаблетка продовженої дії, яка містить похідні в-фенілпропіофенону
DE68907432D1 (de) Beschichtete granulierte duengemittelzusammensetzung und ihre herstellung.
CA2185242A1 (en) Sustained release tablet containing diclofenac-na
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
AU668241B2 (en) Condensed heterocyclic compounds, their production and use
AU585207B2 (en) Hydantoin derivatives, process for producing the same and medicine containing the same.
JPS6468379A (en) Novel compound, its production and pharmaceutical composition containing the same
USD274629S (en) Advertisement pillar
AU3904289A (en) Secondary polyetheramines, their production and use for the production of polyureas
EP0618222A3 (en) Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid.
ZA967537B (en) Novel carboxylic acid derivatives, their preparation and use.
AU697041B2 (en) Mannich base derivatives, and the production and uses thereof